ask="17.00"
ask_size="500"
average_daily_volume="143002"
bid="16.60"
bid_size="100"
book_value="6.55"
change="-0.31"
change_from_200_day_moving_average="1.21"
change_from_50_day_moving_average="0.59"
change_from_52_week_high="-9.48"
change_From_52_week_low="4.57"
change_in_percent="-1.83%"
close="16.59"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-2.91"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="17.04"
high_52_weeks="26.07"
last_trade_date="1/3/2017"
last_trade_price="16.59"
last_trade_size="17581"
last_trade_time="4:00pm"
low="16.05"
low_52_weeks="12.02"
market_capitalization="364.68M"
moving_average_200_day="15.38"
moving_average_50_day="16.00"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="33.57"
open="16.99"
pe_ratio="N/A"
peg_ratio="-0.08"
percent_change_from_200_day_moving_average="+7.85%"
percent_change_from_50_day_moving_average="+3.69%"
percent_change_from_52_week_high="-36.36%"
percent_change_from_52_week_low="+38.02%"
previous_close="16.90"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.58"
price_per_sales="350.80"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="29.71"
stock_exchange="NGM"
symbol="ADMS"
volume="213240"
weeks_range_52="12.02 - 26.07"
